|
GB929406A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
A process for the production of encapsulated material
|
|
GB929401A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Encapsulated emulsions and processes for their preparation
|
|
GB969808A
(en)
|
1962-06-08 |
1964-09-16 |
Boots Pure Drug Co Ltd |
Anthelmintic compositions and compounds
|
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5804178A
(en)
|
1986-11-20 |
1998-09-08 |
Massachusetts Institute Of Technology |
Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
JP2528706B2
(ja)
|
1988-05-30 |
1996-08-28 |
ゼリア新薬工業株式会社 |
ジヒドロピリジン化合物の製剤組成物
|
|
GB8819110D0
(en)
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5013557A
(en)
|
1989-10-03 |
1991-05-07 |
Warner-Lambert Company |
Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
|
|
JP2527107B2
(ja)
|
1991-04-16 |
1996-08-21 |
日本新薬株式会社 |
固体分散体の製造方法
|
|
TW209174B
(OSRAM)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
SE9401109D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Opthalmic composition II
|
|
SE9401108D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Ophthalmic composition I
|
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
TW406022B
(en)
|
1994-12-19 |
2000-09-21 |
Daiichi Seiyaku Co |
Method for producing slow-release granular agents
|
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
|
PT784974E
(pt)
|
1995-07-26 |
2003-09-30 |
Kyowa Hakko Kogyo Kk |
Preparacao de derivados de xantina numa dispersao solida
|
|
US5628984A
(en)
|
1995-07-31 |
1997-05-13 |
University Of North Carolina At Chapel Hill |
Method of detecting lung disease
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
JP2000505068A
(ja)
|
1996-03-13 |
2000-04-25 |
トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア |
補体活性化を阻害する新規ペプチド類
|
|
ATE238068T1
(de)
|
1996-07-01 |
2003-05-15 |
Univ Utrecht |
Hydrolysierbare hydrogele zur gesteuerten freisetzung
|
|
US6395302B1
(en)
|
1996-11-19 |
2002-05-28 |
Octoplus B.V. |
Method for the preparation of microspheres which contain colloidal systems
|
|
EP0842657A1
(en)
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Microspheres for controlled release and processes to prepare these microspheres
|
|
US6653340B1
(en)
|
1997-06-03 |
2003-11-25 |
Biocryst Pharmaceuticals, Inc. |
Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
ATE364374T1
(de)
|
1997-08-11 |
2007-07-15 |
Pfizer Prod Inc |
Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
NZ507760A
(en)
*
|
1998-03-26 |
2002-10-25 |
Japan Tobacco Inc |
Amide derivatives and nociceptin antagonists
|
|
EP1112275B9
(en)
|
1998-09-09 |
2004-03-10 |
Metabasis Therapeutics, Inc. |
Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
|
|
GB9827145D0
(en)
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
|
KR20000047461A
(ko)
|
1998-12-29 |
2000-07-25 |
성재갑 |
트롬빈 억제제
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
EP1219611A4
(en)
|
1999-09-03 |
2003-03-19 |
Ajinomoto Kk |
NEW PROCESSES FOR THE PRODUCTION OF OXAZEPINE DERIVATIVES
|
|
GB9927011D0
(en)
|
1999-11-16 |
2000-01-12 |
Advanced Phytonics Ltd |
Method for the production of particles
|
|
US7078057B2
(en)
|
1999-12-20 |
2006-07-18 |
Kerkhof Nicholas J |
Process for producing nanometer particles by fluid bed spray-drying
|
|
CZ20022047A3
(cs)
|
1999-12-23 |
2003-09-17 |
Pfizer Products Inc. |
Farmaceutické kompozice poskytující zvýšenou koncentraci léčiva
|
|
EA004370B1
(ru)
|
1999-12-23 |
2004-04-29 |
Пфайзер Продактс Инк. |
Лекарственная форма с высвобождением лекарства под действием гидрогеля
|
|
CA2400172C
(en)
|
2000-02-28 |
2010-04-20 |
Genesegues, Inc. |
Nanocapsule encapsulation system and method
|
|
CN100479862C
(zh)
|
2000-04-03 |
2009-04-22 |
参天制药株式会社 |
释放物质和采用该物质的药物释放系统
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
EP1296651B2
(en)
|
2000-06-27 |
2019-07-17 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
|
GB2364919A
(en)
|
2000-07-21 |
2002-02-13 |
Cambridge Consultants |
Inhalers
|
|
GB0021024D0
(en)
|
2000-08-29 |
2000-10-11 |
Glaxo Group Ltd |
Inhalation device
|
|
CN101584867A
(zh)
|
2000-10-31 |
2009-11-25 |
瑟莫迪克斯药品公司 |
提高生物活性分子传递的方法和组合物
|
|
EP1337239B2
(en)
|
2000-11-30 |
2015-11-25 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US7528165B2
(en)
*
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
|
BR0307516A
(pt)
|
2002-02-01 |
2004-12-07 |
Pfizer Prod Inc |
Formas de dosagem de liberação imediata contendo dispersões de uma droga sólida
|
|
ITMI20021527A1
(it)
|
2002-07-11 |
2004-01-12 |
Consiglio Nazionale Ricerche |
Anticorpi anti componente c5 del complemento e loro uso
|
|
NZ537853A
(en)
|
2002-07-16 |
2007-02-23 |
Amura Therapeutics Ltd |
Inhibitors of cathepsin K and related cysteine protesases of the CA clan
|
|
EP2311480B1
(en)
|
2002-09-20 |
2013-06-26 |
The Trustees of The University of Pennsylvania |
Compstatin analogs with improved activity
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
AU2003302084A1
(en)
|
2002-11-15 |
2004-06-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
|
US7431026B2
(en)
*
|
2003-04-22 |
2008-10-07 |
Avalon Advanced Products, Inc |
Paintball refillers and method for making and using same
|
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7482376B2
(en)
|
2003-07-03 |
2009-01-27 |
3-Dimensional Pharmaceuticals, Inc. |
Conjugated complement cascade inhibitors
|
|
US20050009910A1
(en)
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
SG146648A1
(en)
|
2003-09-15 |
2008-10-30 |
Vectura Ltd |
Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
|
|
WO2005027906A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
|
JP4586021B2
(ja)
|
2003-09-23 |
2010-11-24 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
マイクロ流体装置の新規な材料として使用するための光硬化性ペルフルオロポリエーテル
|
|
SE0302665D0
(sv)
|
2003-10-07 |
2003-10-07 |
Astrazeneca Ab |
Novel Process
|
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
|
KR101281775B1
(ko)
|
2003-12-19 |
2013-07-15 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된마이크로- 및 나노- 구조를 제작하는 방법
|
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
DK1713503T3
(da)
|
2004-02-10 |
2013-11-04 |
Univ Colorado Regents |
Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde
|
|
WO2007021762A2
(en)
|
2005-08-09 |
2007-02-22 |
The University Of North Carolina At Chapel Hill |
Methods and materials for fabricating microfluidic devices
|
|
RU2393154C2
(ru)
|
2004-03-24 |
2010-06-27 |
Йерини Аг |
Новые соединения для ингибирования ангиогенеза и их применение
|
|
GB0407627D0
(en)
|
2004-04-02 |
2004-05-05 |
Vectura Ltd |
Corkscrew pump
|
|
CA2562356A1
(en)
|
2004-04-08 |
2005-10-27 |
Retmed Pty Ltd |
Treatment of ophthalmic conditions with mineralcorticoids
|
|
US7417063B2
(en)
|
2004-04-13 |
2008-08-26 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles useful as serine protease inhibitors
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
EP1814576A2
(en)
|
2004-07-20 |
2007-08-08 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
PL370285A1
(pl)
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
CA2594694A1
(en)
|
2005-01-28 |
2006-08-03 |
Pfizer Products Inc. |
Drying of drug-containing particles
|
|
US8617604B2
(en)
|
2005-02-03 |
2013-12-31 |
Bend Research, Inc. |
Pharmaceutical compositions with enhanced performance
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
GB2438544A
(en)
|
2005-02-09 |
2007-11-28 |
Cooper Internat Corp |
Liquid formulations for treatment of diseases or conditions
|
|
AU2006282042B2
(en)
|
2005-06-17 |
2011-12-22 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials
|
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
WO2007056561A2
(en)
|
2005-11-09 |
2007-05-18 |
Liquidia Technologies, Inc. |
Medical device, materials, and methods
|
|
EP1960422B1
(en)
|
2005-11-28 |
2012-05-30 |
The Trustees of The University of Pennsylvania |
Potent compstatin analogs
|
|
TW200730478A
(en)
|
2005-12-12 |
2007-08-16 |
Genelabs Tech Inc |
N-(6-membered aromatic ring)-amido anti-viral compounds
|
|
US20070149593A1
(en)
|
2005-12-23 |
2007-06-28 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
US8944804B2
(en)
|
2006-01-04 |
2015-02-03 |
Liquidia Technologies, Inc. |
Nanostructured surfaces for biomedical/biomaterial applications and processes thereof
|
|
CA2636716C
(en)
|
2006-01-13 |
2014-12-23 |
Surmodics, Inc. |
Microparticle containing matrices for drug delivery
|
|
DK2359834T5
(en)
|
2006-03-15 |
2017-02-06 |
Alexion Pharma Inc |
Treatment of paroxysmal nocturnal hemoglobinuria patients with a complement inhibitor
|
|
CN101443004B
(zh)
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
WO2007133808A2
(en)
|
2006-05-15 |
2007-11-22 |
Liquidia Technologies, Inc. |
Nano-particles for cosmetic applications
|
|
SI2041156T1
(sl)
*
|
2006-07-13 |
2014-04-30 |
Achillion Pharmacetuticals, Inc. |
Peptidi 4-amino-4-oksobutanoila kot inhibitorji virusne replikacije
|
|
WO2008013952A2
(en)
|
2006-07-27 |
2008-01-31 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
|
|
GB0617480D0
(en)
|
2006-09-06 |
2006-10-18 |
Univ Sheffield |
Novel nanoparticles
|
|
ES2360538T3
(es)
|
2006-09-08 |
2011-06-06 |
Johns Hopkins University |
Composiciones para aumentar el transporte a través de moco.
|
|
US9022970B2
(en)
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
|
JPWO2008047831A1
(ja)
|
2006-10-17 |
2010-02-25 |
協和発酵キリン株式会社 |
Ｊａｋ阻害剤
|
|
ZA200902587B
(en)
|
2006-11-09 |
2010-06-30 |
Alcon Res Ltd |
Water insoluble polymer matrix for drug delivery
|
|
WO2008100304A2
(en)
|
2006-11-15 |
2008-08-21 |
The University Of North Carolina At Chapel Hill |
Polymer particle composite having high fidelity order, size, and shape particles
|
|
DK2119703T3
(da)
|
2007-01-15 |
2013-01-14 |
Santen Pharmaceutical Co Ltd |
Nyt indolderivat med inhiberende virkning på I-B-kinase.
|
|
EP2148691B1
(en)
|
2007-02-05 |
2015-05-20 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogues for use in the treatment of inflammatory conditions of the respiratory system
|
|
BRPI0817664A2
(pt)
|
2007-10-12 |
2015-03-24 |
Massachusetts Inst Technology |
Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
|
|
MX2010006422A
(es)
|
2007-12-11 |
2010-06-25 |
Glaxo Group Ltd |
Proteinas de union a antigenos.
|
|
AU2008339917B2
(en)
|
2007-12-24 |
2013-02-07 |
Tibotec Pharmaceuticals |
Macrocyclic indoles as hepatitis C virus inhibitors
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
US20090203709A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
|
|
EP2276420B1
(en)
|
2008-04-04 |
2021-10-06 |
Journey1, Inc. |
Device to treat an eye having an epithelium with a defect
|
|
WO2009132206A1
(en)
|
2008-04-25 |
2009-10-29 |
Liquidia Technologies, Inc. |
Compositions and methods for intracellular delivery and release of cargo
|
|
WO2009132265A2
(en)
|
2008-04-25 |
2009-10-29 |
The University Of North Carolina At Chapel Hill |
Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
|
|
WO2010009087A1
(en)
|
2008-07-15 |
2010-01-21 |
Eyegate Pharmaceuticals, Inc. |
Iontophoretic delivery of a controlled-release formulation in the eye
|
|
WO2010015608A1
(en)
|
2008-08-05 |
2010-02-11 |
Novartis Ag |
Compositions and methods for antibodies targeting complement protein c5
|
|
UA101056C2
(ru)
|
2008-10-08 |
2013-02-25 |
Астразенека Аб |
Ингаляционное устройство и способ дозированной подачи медикамента
|
|
KR101690643B1
(ko)
|
2008-12-05 |
2016-12-28 |
리퀴디아 테크놀로지스 인코포레이티드 |
패턴 재료 제조 방법
|
|
CA3045436C
(en)
|
2009-01-29 |
2025-10-07 |
Forsight Vision4 Inc |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US20120052041A1
(en)
|
2009-02-04 |
2012-03-01 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
|
CA2752018C
(en)
|
2009-02-10 |
2017-07-04 |
Psivida Us, Inc. |
Ocular trocar assembly
|
|
ES2655714T3
(es)
|
2009-02-26 |
2018-02-21 |
The University Of North Carolina At Chapel Hill |
Sistema intervencionista de administración de fármacos
|
|
ES2655389T3
(es)
|
2009-05-01 |
2018-02-19 |
The Trustees Of The University Of Pennsylvania |
Compstatina modificada con esqueleto peptídico y modificaciones c-terminales
|
|
US10952965B2
(en)
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
|
US9291622B2
(en)
|
2009-05-21 |
2016-03-22 |
Apellis Pharmaceuticals, Inc. |
Complement assays and uses thereof
|
|
JP5695035B2
(ja)
|
2009-06-03 |
2015-04-01 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
前眼部薬物供給
|
|
WO2011008737A2
(en)
|
2009-07-13 |
2011-01-20 |
The University Of North Carolina At Chapel Hill |
Engineered aerosol particles, and associated methods
|
|
TWI492769B
(zh)
|
2009-09-23 |
2015-07-21 |
Alcon Res Ltd |
可注射的水性眼用組成物及其使用之方法
|
|
US8410139B2
(en)
*
|
2009-10-07 |
2013-04-02 |
Bristol-Myers Squibb Company |
Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
|
|
JP5758298B2
(ja)
|
2009-10-16 |
2015-08-05 |
持田製薬株式会社 |
非アルコール性脂肪肝炎関連マーカー
|
|
ES2649890T3
(es)
|
2009-10-23 |
2018-01-16 |
Nexisvision, Inc. |
Enervación corneal para el tratamiento de dolor ocular
|
|
US9498385B2
(en)
|
2009-10-23 |
2016-11-22 |
Nexisvision, Inc. |
Conformable therapeutic shield for vision and pain
|
|
EA201290286A1
(ru)
|
2009-11-05 |
2013-01-30 |
Алексион Кембридж Корпорейшн |
Лечение пароксизмальной ночной гемоглобинурии, гемолитических анемий и патологических состояний с вовлечением внутрисосудистого и внесосудистого гемолиза
|
|
TWI478730B
(zh)
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
|
EP2719699B1
(en)
|
2009-12-31 |
2015-07-08 |
Hutchison Medipharma Limited |
Certain triazolopyrazines, compositions thereof and methods of use therefor
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
WO2011106702A2
(en)
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
US20130071349A1
(en)
|
2010-03-02 |
2013-03-21 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
|
RU2603008C2
(ru)
|
2010-04-16 |
2016-11-20 |
Ац Иммуне С.А. |
Новые соединения для лечения заболеваний, связанных с амилоидными или амилоидоподобными белками
|
|
BR112012028308B1
(pt)
|
2010-05-05 |
2021-09-28 |
Alcon Inc. |
Formulações oftálmicas de galactomanano estabilizadas, e seu método de fabricação
|
|
WO2011153349A1
(en)
|
2010-06-02 |
2011-12-08 |
Alcon Research, Ltd. |
Ophthalmic compositions comprising pbo-peo-pbo block copolymers
|
|
WO2011163394A2
(en)
|
2010-06-22 |
2011-12-29 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of neuropathic pain
|
|
US20130324482A1
(en)
|
2010-07-09 |
2013-12-05 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of rhinosinusitis and nasal polyposis
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
EP2600920A4
(en)
|
2010-08-05 |
2017-10-04 |
Forsight Vision4, Inc. |
Subconjunctival implant for posterior segment drug delivery
|
|
HUE054113T2
(hu)
|
2010-08-05 |
2021-08-30 |
Forsight Vision4 Inc |
Injekciós készülék gyógyszerbejuttatáshoz
|
|
HUE057267T2
(hu)
|
2010-08-05 |
2022-05-28 |
Forsight Vision4 Inc |
Berendezés szem kezelésére
|
|
US9084976B2
(en)
|
2010-09-03 |
2015-07-21 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
CA2816977C
(en)
|
2010-11-05 |
2019-10-29 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
US20140033800A1
(en)
|
2010-11-11 |
2014-02-06 |
Forsight Vision4, Inc. |
Methods and apparatus to determine diffusion properties of porous structures for drug delivery
|
|
TW201304822A
(zh)
|
2010-11-15 |
2013-02-01 |
Vectura Ltd |
組成物及用途
|
|
EP2640360A2
(en)
|
2010-11-19 |
2013-09-25 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012093101A1
(en)
*
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
WO2012145801A1
(en)
|
2011-04-29 |
2012-11-01 |
Jagat Rakesh Kanwar |
Nanoparticle
|
|
US9060938B2
(en)
|
2011-05-10 |
2015-06-23 |
Bend Research, Inc. |
Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
|
|
CN107050422B
(zh)
|
2011-05-11 |
2021-11-09 |
阿佩利斯制药公司 |
细胞反应性的、长效的或靶向的坎普他汀类似物及其用途
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
US8809313B2
(en)
*
|
2011-05-27 |
2014-08-19 |
Achillion Pharmaceuticals, Inc. |
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
|
|
WO2012177782A1
(en)
|
2011-06-20 |
2012-12-27 |
Myrexis, Inc. |
Compounds and therapeutic uses thereof
|
|
CN103796667A
(zh)
|
2011-06-22 |
2014-05-14 |
艾普莱斯制药公司 |
用补体抑制剂治疗慢性障碍的方法
|
|
US20130035392A1
(en)
|
2011-08-01 |
2013-02-07 |
Mcgeer Patrick L |
Selective inhibition of the membrane attack complex of complement and C3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex
|
|
PL2753636T3
(pl)
|
2011-09-07 |
2020-05-18 |
The Trustees Of The University Of Pennsylvania |
Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych
|
|
ES2912370T3
(es)
|
2011-09-14 |
2022-05-25 |
Forsight Vision5 Inc |
Aparato para inserción ocular
|
|
GB201115874D0
(en)
|
2011-09-14 |
2011-10-26 |
Astrazeneca Ab |
Inhaler
|
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
|
WO2013082111A2
(en)
|
2011-11-29 |
2013-06-06 |
The University Of North Carolina At Chapel Hill |
Geometrically engineered particles and methods for modulating macrophage or immune responses
|
|
AU2012351994B2
(en)
|
2011-12-14 |
2015-11-05 |
The Johns Hopkins University |
Nanoparticles with enhanced mucosal penetration or decreased inflammation
|
|
KR101831217B1
(ko)
|
2011-12-27 |
2018-02-22 |
벡투라 게엠베하 |
피드백 시스템을 가지는 흡입 장치
|
|
KR101811917B1
(ko)
|
2012-01-19 |
2017-12-22 |
더 존스 홉킨스 유니버시티 |
점액 침투 강화를 나타내는 나노 입자 제형
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
WO2013132056A1
(en)
|
2012-03-09 |
2013-09-12 |
Activaero Gmbh |
Mixing channel for an inhalation device and inhalation device
|
|
EP2825207B1
(en)
|
2012-03-16 |
2020-08-19 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
|
US9056057B2
(en)
|
2012-05-03 |
2015-06-16 |
Kala Pharmaceuticals, Inc. |
Nanocrystals, compositions, and methods that aid particle transport in mucus
|
|
NZ741873A
(en)
|
2012-05-03 |
2019-04-26 |
Kala Pharmaceuticals Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US9056874B2
(en)
|
2012-05-04 |
2015-06-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
HK1208377A1
(en)
|
2012-05-04 |
2016-03-04 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
KR20150003903A
(ko)
|
2012-05-04 |
2015-01-09 |
노파르티스 아게 |
보체 경로 조절제 및 그의 용도
|
|
CN118924900A
(zh)
*
|
2012-06-18 |
2024-11-12 |
奥默罗斯公司 |
抑制masp-1和/或masp-2和/或masp-3的组合物和方法
|
|
EP2864322B1
(en)
|
2012-06-20 |
2016-04-27 |
Novartis AG |
Complement pathway modulators and uses thereof
|
|
US9579360B2
(en)
|
2012-06-20 |
2017-02-28 |
The Trustees Of The University Of Pennsylvania |
Methods of treating or preventing periodontitis and diseases associated with periodontitis
|
|
JP6273274B2
(ja)
|
2012-06-28 |
2018-01-31 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
|
ES2712190T3
(es)
*
|
2012-06-28 |
2019-05-09 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
|
JP6209605B2
(ja)
|
2012-06-28 |
2017-10-04 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
JP6155332B2
(ja)
*
|
2012-06-28 |
2017-06-28 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
WO2014002052A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
MX2014015738A
(es)
*
|
2012-06-28 |
2015-08-06 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la senda del complemento.
|
|
WO2014002059A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide
|
|
WO2014005150A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
Crystalline forms of l-(2-((lr,3s,5r)-3-( (2 -fluoro-3 - (trifluoromethoxy) phenyl) carbamoyl) - 2 -azabicycl o [3.1.0] hexan- 2 -yl) - 2 -oxoethyl) - 5 -methyl - 1h - pyrazolo [3, 4 -c] pyridine - 3 - carboxami de and salts thereof
|
|
EA201590200A1
(ru)
*
|
2012-07-12 |
2015-08-31 |
Новартис Аг |
Модуляторы пути активации комплемента и их применение
|
|
ES1077714Y
(es)
|
2012-07-31 |
2012-12-20 |
Gutierrez Jose Ramon Perez |
Envase de madera
|
|
KR20150054795A
(ko)
|
2012-09-10 |
2015-05-20 |
에프. 호프만-라 로슈 아게 |
B형 간염 바이러스 감염의 치료 및 예방을 위한 6-아미노산 헤테로아릴다이하이드로피리미딘
|
|
WO2014043625A1
(en)
|
2012-09-17 |
2014-03-20 |
Bind Therapeutics, Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
KR20150090038A
(ko)
|
2012-09-20 |
2015-08-05 |
아키나, 인크. |
충전재를 함유한 생분해성 미세캡슐
|
|
CN104884006B
(zh)
|
2012-10-26 |
2017-12-15 |
弗赛特影像5股份有限公司 |
用于持续释放药物到眼睛的眼科系统
|
|
SI2724741T1
(sl)
|
2012-10-26 |
2017-10-30 |
Vectura Gmbh |
Inhalacijska naprava za uporabo v terapiji z aerosolom
|
|
CA2891673C
(en)
|
2012-11-15 |
2025-10-07 |
Apellis Pharmaceuticals Inc |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
WO2014078734A2
(en)
|
2012-11-15 |
2014-05-22 |
Apellis Pharmaceuticals, Inc. |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
US9773428B2
(en)
|
2012-12-11 |
2017-09-26 |
Fluidity Software, Inc. |
Computerized system and method for teaching, learning, and assessing step by step solutions to stem problems
|
|
HK1218300A1
(zh)
|
2013-01-23 |
2017-02-10 |
Musc Foundation For Research Development |
基於天然抗體的靶向結構體及其應用
|
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
JP6387391B2
(ja)
|
2013-03-14 |
2018-09-05 |
ノバルティス アーゲー |
眼科疾患の処置に有用な補体因子Ｂ阻害剤としての２−（１Ｈ−インドール−４−イルメチル）−３Ｈ−イミダゾ［４，５−ｂ］ピリジン−６−カルボニトリル誘導体
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
ES2972168T3
(es)
|
2013-03-28 |
2024-06-11 |
Forsight Vision4 Inc |
Implante oftálmico para administración de sustancias terapéuticas
|
|
CN105188666A
(zh)
|
2013-04-01 |
2015-12-23 |
阿勒根公司 |
用于持续的眼内释放的微球药物递送系统
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
JP2016169161A
(ja)
|
2013-07-19 |
2016-09-23 |
大日本住友製薬株式会社 |
新規イミダゾピリジン化合物
|
|
AU2014306002B2
(en)
|
2013-08-07 |
2017-05-25 |
Alexion Pharmaceuticals, Inc. |
Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
|
|
WO2015054569A1
(en)
|
2013-10-10 |
2015-04-16 |
Viropharma Holdings Limited |
Methods of inhibiting the alternative pathway of complement immune system activation and compositions used therein
|
|
CA2927321A1
(en)
|
2013-10-15 |
2015-04-23 |
Forsight Vision5, Inc. |
Formulations and methods for increasing or reducing mucus
|
|
EP3089963A1
(en)
|
2013-10-30 |
2016-11-09 |
Novartis AG |
2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
|
|
CN106132397A
(zh)
|
2013-12-06 |
2016-11-16 |
恩维希亚治疗股份有限公司 |
用于治疗眼部疾病的前房内植入物
|
|
AP2016009438A0
(en)
|
2014-02-25 |
2016-09-30 |
Achillion Pharmaceuticals Inc |
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
|
|
AR105808A1
(es)
|
2015-08-26 |
2017-11-08 |
Achillion Pharmaceuticals Inc |
Compuestos de amida para el tratamiento de trastornos médicos
|
|
WO2017035405A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of immune and inflammatory disorders
|
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
|
WO2017035348A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Alkyne compounds for treatment of medical disorders
|
|
EP3340982B1
(en)
|
2015-08-26 |
2021-12-15 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
|
WO2017035351A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of medical disorders
|
|
WO2017035418A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Disubstituted compounds for treatment of immune and inflammatory disorders
|
|
WO2017035362A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Use of complement pathway inhibitor compounds to mitigate adoptive t-cell therapy associated adverse immune responses
|
|
WO2017035401A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amide compounds for treatment of immune and inflammatory disorders
|
|
WO2017035352A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Carbamate, ester, and ketone compounds for treatment of medical disorders
|
|
WO2017035355A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Ether compounds for treatment of medical disorders
|
|
WO2017035411A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Ether compounds for treatment of immune and inflammatory disorders
|
|
US10000516B2
(en)
|
2015-08-26 |
2018-06-19 |
Achillion Pharmaceuticals, Inc. |
Phosphonate compounds for treatment of medical disorders
|
|
WO2017035413A2
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Carbamate, ester, and ketone compounds for treatment of immune and inflammatory disorders
|
|
WO2017035415A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Alkyne compounds for treatment of immune and inflammatory disorders
|
|
AR105809A1
(es)
|
2015-08-26 |
2017-11-08 |
Achillion Pharmaceuticals Inc |
Compuestos para el tratamiento de trastornos médicos
|
|
WO2017035417A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Phosphonate compounds for treatment of immune and inflammatory disorders
|
|
EP3340983B1
(en)
|
2015-08-26 |
2023-10-04 |
Achillion Pharmaceuticals, Inc. |
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
|
|
WO2017035361A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Disubstituted compounds for the treatment of medical disorders
|
|
US20190127366A1
(en)
|
2015-12-11 |
2019-05-02 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
MA43872A
(fr)
|
2016-01-14 |
2021-05-19 |
Chemocentryx Inc |
Procédé de traitement d'une glomérulopathie à c3
|
|
CN108934169A
(zh)
|
2016-01-20 |
2018-12-04 |
维特里萨医疗公司 |
用于抑制因子d的组合物和方法
|
|
TWI854164B
(zh)
|
2016-02-01 |
2024-09-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
AU2017290593A1
(en)
|
2016-06-27 |
2019-01-03 |
Achillion Pharmaceuticals, Inc. |
Quinazoline and indole compounds to treat medical disorders
|
|
JOP20170154B1
(ar)
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
EP3589287B1
(en)
|
2017-03-01 |
2022-09-14 |
Achillion Pharmaceuticals, Inc. |
Macrocyclic compounds for treatment of medical disorders
|
|
CN110603252A
(zh)
|
2017-03-01 |
2019-12-20 |
艾其林医药公司 |
用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
|
|
WO2018160891A1
(en)
|
2017-03-01 |
2018-09-07 |
Achillion Pharmaceutical, Inc. |
Pharmaceutical compounds for treatment of medical disorders
|
|
EP3661493A4
(en)
|
2017-08-02 |
2021-04-14 |
Achillion Pharmaceuticals, Inc. |
TREATMENT DIET FOR THE TREATMENT OF PAROXYSTIC NOCTURAL HEMOGLOBINURIA
|
|
EP3692064A1
(en)
|
2017-10-04 |
2020-08-12 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-c5 antibodies for treatment of patients with membranoproliferative glomerulonephritis
|
|
US11759472B2
(en)
|
2017-11-21 |
2023-09-19 |
Cs Pharmaceuticals Limited |
Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
EP3856164B1
(en)
|
2018-09-25 |
2024-08-07 |
Achillion Pharmaceuticals, Inc. |
Morphic forms of complement factor d inhibitors
|
|
WO2020109343A1
(en)
|
2018-11-29 |
2020-06-04 |
F. Hoffmann-La Roche Ag |
Combination therapy for treatment of macular degeneration
|
|
US12239645B2
(en)
|
2018-12-17 |
2025-03-04 |
Achillion Pharmaceuticals, Inc. |
Targeted dosing for the treatment of complement mediated disorders
|
|
AU2020323532A1
(en)
|
2019-07-31 |
2022-03-03 |
Biocryst Pharmaceuticals, Inc. |
Dosing regimens for oral complement Factor D inhibitors
|
|
CN112280762B
(zh)
*
|
2020-11-13 |
2022-11-01 |
中山俊凯生物技术开发有限公司 |
一种烟酰胺核糖激酶突变体及其编码基因和应用
|
|
CN113832125B
(zh)
*
|
2021-10-19 |
2023-09-26 |
中山百灵生物技术股份有限公司 |
一种烟酰胺核糖激酶突变体及其编码基因和应用
|
|
CN114107160B
(zh)
*
|
2021-12-27 |
2025-04-25 |
浙江英沃迪生物科技有限公司 |
一种烟酰胺核糖激酶基因工程菌及其应用
|
|
CN114606213B
(zh)
*
|
2022-01-28 |
2024-05-03 |
浙江工业大学 |
一种多聚磷酸激酶突变体、工程菌及其应用
|